JCY International Berhad (KLSE:JCY)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions MYR. Fiscal year is October - September.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Market Capitalization	640	927	401	285	644	1,476
Market Cap Growth	53.52%	131.22%	40.74%	-55.73%	-56.38%	321.26%
Enterprise Value	465	807	311	194	411	1,178
Last Close Price	0.30	0.43	0.19	0.14	0.30	0.70
PE Ratio	41.60	32.19	-	-	-	56.61
PS Ratio	1.13	1.53	0.84	0.34	0.61	1.37
PB Ratio	0.97	1.38	0.59	0.36	0.74	1.60
P/TBV Ratio	0.97	1.38	0.59	0.37	0.75	1.60
P/FCF Ratio	6.74	11.29	-	-	-	-
P/OCF Ratio	6.16	10.40	-	-	-	-
PEG Ratio	-	1.26	1.26	1.26	1.26	1.26
EV/Sales Ratio	0.82	1.33	0.66	0.23	0.39	1.10
EV/EBITDA Ratio	87.52	23.25	-	-	-	15.99
EV/EBIT Ratio	-	340.46	-	-	-	29.02
EV/FCF Ratio	4.91	9.82	-	-	-	-
Debt / Equity Ratio	0.05	0.05	0.07	0.09	0.12	0.07
Debt / EBITDA Ratio	6.28	0.91	-	-	-	0.90
Debt / FCF Ratio	0.35	0.40	-	-	-	-
Asset Turnover	0.74	0.77	0.55	0.79	0.91	0.96
Inventory Turnover	3.14	2.85	2.00	3.10	4.85	5.18
Quick Ratio	3.62	3.35	2.52	1.75	2.04	2.78
Current Ratio	5.51	5.10	4.76	3.87	2.93	3.82
Return on Equity (ROE)	2.30%	4.25%	-12.31%	-10.80%	-3.95%	2.88%
Return on Assets (ROA)	-2.16%	0.19%	-7.46%	-5.23%	-3.73%	2.27%
Return on Capital (ROIC)	-2.36%	0.21%	-8.21%	-6.04%	-4.40%	2.63%
Return on Capital Employed (ROCE)	-	0.40%	-	-	-	4.30%
Earnings Yield	2.42%	3.11%	-22.52%	-31.30%	-5.50%	1.77%
FCF Yield	14.83%	8.86%	-11.70%	-44.42%	-8.87%	-3.68%
Payout Ratio	-	-	-	-	-	39.52%
Buyback Yield / Dilution	-1.54%	-1.22%	0.91%	-0.68%	0.11%	-2.77%
Total Shareholder Return	-	-1.22%	0.91%	-0.68%	0.11%	-2.77%

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.